1
|
A new strategy for the synthesis of oxo-rhenium(V) porphyrins: Synthesis, characterization, theoretical calculations and electrochemical aspects. Inorganica Chim Acta 2023. [DOI: 10.1016/j.ica.2022.121344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|
2
|
Sanad MH, Gizawy MA, Motaleb MA, Ibrahim IT, Saad EA. A Comparative Study of Stannous Chloride and Sodium Borohydride as Reducing Agents for the Radiolabeling of 2,3,7,8,12,13,17,18-Octaethyl-21H,23H-Porphine with Technetium-99m for Tumor Imaging. RADIOCHEMISTRY 2021. [DOI: 10.1134/s1066362221040159] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
3
|
Gizawy MA, El-Tahawy MMT, Motaleb MA. Radiosynthesis, molecular modeling and biodistribution of 99mTc-Protoporphyrin as a preclinical model for tumor diagnosis. J PORPHYR PHTHALOCYA 2020. [DOI: 10.1142/s1088424620500352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Porphyrins are among the most important and widely used compounds involved in a variety of chemical and biochemical applications. These molecules exhibit very special properties that encourage researchers to label many derivatives with diagnostic or therapeutic radionuclides for medical applications. This study reports the radiolabeling and biodistribution of [Formula: see text]Tc-protoporphyrin IX ([Formula: see text]Tc-PPIX) as a novel potential solid-tumor imaging agent. The factors affecting the radiolabeling process were varied to achieve maximum radiochemical yield. [Formula: see text]Tc-PPIX was obtained in high yield of 97.34 ± 0.21% and high stability in serum up to 24 h. The radiochemical yield of [Formula: see text]Tc-PPIX was assessed by a combination of a paper chromatographic technique and HPLC. A computational analysis for all the potential structures that may be formed due to the interaction between protoporphyrin IX and technetium was performed via the DFT method of calculations in gas phase to predict the most likely structure. Molecular docking was further employed to shed light on the nature of the interaction between the most stable complexes with the target protein. Finally, the in-vivo biodistribution of [Formula: see text]Tc-PPIX complex was evaluated in solid-tumor-bearing mice and high tumor/tissue ratio of 5.17 ± 0.34 at 60 min post injection was obtained. Our finding clearly suggests [Formula: see text]Tc-PPIX as a potential SPECT agent for tumor imaging.
Collapse
Affiliation(s)
- Mohamed A. Gizawy
- Labeled Compounds Department, Hot Labs Center, Atomic Energy Authority, P.O. Box 13759, Cairo, Egypt
- Radioisotopes Production Facility (RPF), Egyptian Second Research Reactor (ETRR-2), Atomic Energy Authority, P.O. Box 13759, Cairo, Egypt
| | | | - Mohamed A. Motaleb
- Labeled Compounds Department, Hot Labs Center, Atomic Energy Authority, P.O. Box 13759, Cairo, Egypt
| |
Collapse
|
4
|
Sanad MH, Farag AB, Saleh GM. Radiosynthesis and Biological Evaluation of 188Re-5,10,15,20-Tetra(4-pyridyl)-21H,23H-porphyrin Complex as a Tumor-Targeting Agent. RADIOCHEMISTRY 2019. [DOI: 10.1134/s106636221903010x] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
|
5
|
Song H, Wang G, Wang J, Wang Y, Wei H, He J, Luo S. 131I-labeled 5,10,15,20-tetrakis(4-hydroxyphenyl)porphyrin and 5,10,15,20-tetrakis(4-aminophenyl)porphyrin for combined photodynamic and radionuclide therapy. J Radioanal Nucl Chem 2018. [DOI: 10.1007/s10967-018-5735-2] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
6
|
Zolghadri S, Yousefnia H, Jalilian AR, Fazaeli Y. Production, quality control, biodistribution assessment and preliminary dose evaluation of [177Lu]-tetra phenyl porphyrin complex as a possible therapeutic agent. BRAZ J PHARM SCI 2015. [DOI: 10.1590/s1984-82502015000200011] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
<p>Due to interesting therapeutic properties of <sup>177</sup>Lu and tumor avidity of tetraphenyl porphyrins (TPPs), <sup>177</sup>Lu-tetraphenyl porphyrin was developed as a possible therapeutic compound. <sup>177</sup>Lu of 2.6-3 GBq/mg specific activity was obtained by irradiation of natural Lu<sub>2</sub>O<sub>3</sub>sample with thermal neutron flux of 4 × 10<sup>13</sup> n.cm<sup>-2</sup>.s<sup>-1</sup>. Tetraphenyl porphyrin was synthetized and labeled with <sup>177</sup>Lu. Radiochemical purity of the complex was studied using Instant thin layer chromatography (ITLC) method. Stability of the complex was checked in final formulation and human serum for 48 h. The biodistribution of the labeled compound in vital organs of wild-type rats was studied up to 7 d. The absorbed dose of each human organ was calculated by medical internal radiation dose (MIRD) method. A detailed comparative pharmacokinetic study was performed for <sup>177</sup>Lu cation and [<sup>177</sup>Lu]-TPP. The complex was prepared with a radiochemical purity: >97±1% and specific activity: 970-1000 MBq/mmol. Biodistribution data and dosimetric results showed that all tissues receive approximately an insignificant absorbed dose due to rapid excretion of the complex through the urinary tract. [<sup>177</sup>Lu]-TPP can be an interesting tumor targeting agent due to low liver uptake and very low absorbed dose of approximately 0.036 to the total body of human.</p>
Collapse
|
7
|
Synthesis and characterization of novel water-soluble 117mSn labeled porphyrin conjugates. J Radioanal Nucl Chem 2015. [DOI: 10.1007/s10967-015-4042-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
8
|
Sun ZZ, Wei HY, Wang GQ, Zhou ZJ, He JH, Wang J, Luo SZ. Preparation and the biodistribution study of [131I]-5,10,15,20-tetrakis(4-hydroxyphenyl)porphyrin and 5-(4-aminophenyl)-10,15,20-triphenylporphyrin. J Radioanal Nucl Chem 2014. [DOI: 10.1007/s10967-014-3269-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
9
|
Motaleb MA, Nassar MY. Preparation, molecular modeling and biodistribution of 99mTc-phytochlorin complex. J Radioanal Nucl Chem 2014. [DOI: 10.1007/s10967-014-2920-9] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
10
|
Waghorn PA. Radiolabelled porphyrins in nuclear medicine. J Labelled Comp Radiopharm 2013; 57:304-9. [PMID: 24353174 DOI: 10.1002/jlcr.3166] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2013] [Accepted: 10/29/2013] [Indexed: 11/09/2022]
Abstract
Amongst tumour-specific substances, hematoporphyrin and synthetic porphyrin derivatives have been widely investigated to identify and delineate neoplastic and malignant tissue. Whilst the tumour localization exhibited by selected porphyrin species has been exploited through photodynamic therapy, several examples of porphyrin derivatives with varied peripheral functionality have been radiolabelled with the aim of developing porphyrin-based nuclear imaging and therapeutic agents. In this review, we look at the approaches and advances in the preparation and uses of such radiolabelled agents for imaging and therapy.
Collapse
Affiliation(s)
- Philip A Waghorn
- CR-UK/MRC Gray Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Oxford, OX3 7LE, UK; Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK
| |
Collapse
|
11
|
Mohammadi K, Hasaninejad A, Niad M, Najmi M. Application of metalloporphyrins as new catalysts for the efficient, mild and regioselective synthesis of quinoxaline derivatives. J PORPHYR PHTHALOCYA 2012. [DOI: 10.1142/s108842461000294x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
A simple, highly efficient and green procedure for the condensation of aryl and alkyl 1,2-diamines with α-diketones in the presence of catalytic amounts of metalloporphyrins at room temperature is described. Using this method, quinoxaline derivatives as biologically interesting compounds are produced in high to excellent yields and short reaction times. In this report, the effects of central metal in porphyrin core and substituents on tetraphenylporphyrin skeleton have been studied.
Collapse
Affiliation(s)
- Khosro Mohammadi
- Chemistry Department, Faculty of Sciences, Persian Gulf University, Bushehr 75169, Iran
| | - Alireza Hasaninejad
- Chemistry Department, Faculty of Sciences, Persian Gulf University, Bushehr 75169, Iran
| | - Mahmud Niad
- Chemistry Department, Faculty of Sciences, Persian Gulf University, Bushehr 75169, Iran
| | - Mojtaba Najmi
- Chemistry Department, Faculty of Sciences, Persian Gulf University, Bushehr 75169, Iran
| |
Collapse
|
12
|
Yang Y, Song H, Song H, Zhao W, Pu M. Preparation of 99mTc(CO)3-TPPS4 and its biological behavior evaluation. J PORPHYR PHTHALOCYA 2012. [DOI: 10.1142/s1088424611003240] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
99mTc(CO)3-TPPS4 was prepared via the precursor [99mTc(CO)3(H2O)3]+ and a preliminary investigation on its stability and behavior in Hep2 tumor cells and hepatoma-bearing mice were conducted. Labeling yield and stability of 99mTc(CO)3-TPPS4 was radioactively analyzed by paper chromatography. Hep2 tumor cells were incubated with 99mTc(CO)3-TPPS4 complex system in the substrate and isolated from the substrate for radioactivity count. Then 99mTc(CO)3-TPPS4 complex system was intravenously injected in hepatoma-bearing mice and directly injected in tumor tissue of the mice. Mice were photographed using SPECT. Labeling yields of 99mTc(CO)3-TPPS4 were more than 90% at pH = 7–8, 30 min, in a boiling bath, and it was stable for at least 14 h at pH = 2–8, rt ~95 °C. The uptake of 99mTc(CO)3-TPPS4 in HepG2 tumor cells was only 3–4% with the maximum uptake-time of 20 min. The SPECT images of hepatoma-bearing nude mice showed no uptake or little retention of 99mTc(CO)3-TPPS4 in the tumor tissue. Then the differences between 99mTc(CO)3-TPPS4 and TPPS4 were analyzed by fluoroscopy and molecular structure. It was found that the paper chromatography, HepG2 tumor cell uptake and the optimized porphyrin ring conformation of 99mTc(CO)3-TPPS4 were quite different from those of TPPS4. It was indicated that 99mTc(CO)3-TPPS4 had no uptake or little retention in hepatic tumors, unlike those biological behaviors of TPPS4. This may be due to the modification of porphyrin ring conformation of TPPS4 by 99mTc(CO)3 core.
Collapse
Affiliation(s)
- Yuqing Yang
- Institute of Nuclear Physics and Chemistry, Mianyang, Sichuan 621900, China
| | - Hu Song
- Institute of Nuclear Physics and Chemistry, Mianyang, Sichuan 621900, China
| | - Hongtao Song
- Institute of Nuclear Physics and Chemistry, Mianyang, Sichuan 621900, China
| | - Weiwei Zhao
- Department of Nuclear Medicine, Sichuan University, Chengdu, Sichuan 610041, China
| | - Manfei Pu
- Institute of Nuclear Physics and Chemistry, Mianyang, Sichuan 621900, China
| |
Collapse
|
13
|
Guo DC, Li PL, Wang X, Wang LY, Wu PL. Synthesis and Characterization of Six New Carbazolyl Porphyrins. SYNTHETIC COMMUN 2010. [DOI: 10.1080/00397910903419811] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
14
|
Das T, Chakraborty S, Sarma HD, Banerjee S, Venakatesh M. A novel 177Lu-labeled porphyrin for possible use in targeted tumor therapy. Nucl Med Biol 2010; 37:655-63. [DOI: 10.1016/j.nucmedbio.2010.02.007] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2009] [Revised: 02/09/2010] [Accepted: 02/28/2010] [Indexed: 10/19/2022]
|
15
|
Sarma HD, Das T, Banerjee S, Venkatesh M, Vidyasagar PB, Mishra KP. Biologic Evaluation of a Novel 188Re-Labeled Porphyrin in Mice Tumor Model. Cancer Biother Radiopharm 2010; 25:47-54. [DOI: 10.1089/cbr.2009.0675] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Haladhar D. Sarma
- Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, India
| | - Tapas Das
- Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India
| | - Sharmila Banerjee
- Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India
| | - Meera Venkatesh
- Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India
| | | | - Kaushala P. Mishra
- Radiation and Cancer Biology Laboratory, Department of Life Science, University of Mumbai, Mumbai, India
| |
Collapse
|